Biocon LtdPharmaceuticalsINE376G01013Consolidated₹385.00+5.00 (+1.32%)Jun-26
Valuation
Market Cap₹62.74K Cr
TTM PE113.24x
Forward PE105.38x
PEG5.18
Book Value₹208.82
P/B1.84x
TTM EPS₹3.40
Fwd EPS₹3.65
TTM Revenue₹17.32K Cr
TTM PAT₹416.40 Cr
TTM EBITDA₹3.54K Cr
TTM EBIT₹1.49K Cr
Last Qtr PAT₹136.80 Cr
Last Qtr EBITDA₹847.20 Cr
Last Qtr EBIT₹299.80 Cr
Profitability
ROE1.22%
ROCE2.98%
TTM NPM2.40%
TTM EBITDA %20.42%
Curr OPM3.12%
Last OPM4.35%
Curr NPM—
Last NPM—
Curr EPS₹0.87
Last EPS₹0.79
Balance sheet
Equity₹810.50 Cr
Reserve₹33.22K Cr
Total Debt₹15,434.10 Cr
D/E0.45x
Interest %155.85%
Curr Interest₹213.20 Cr
Price / range
Close₹385.00
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+1.32%
1W-1.45%
1M-7.78%
3M-6.97%
6M+0.71%
1Y+4.52%
2Y+5.87%
3Y+41.00%
5Y+2.01%
Diwali-0.71%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits